Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zemuron vs Norcuron in Elective Surgery
NCT00970762Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2003
- Primary completion
- Feb 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of rocuronium, sponsored by Merck & Co.. Started Feb 2003; status: completed.
02
Drugs
rocuronium
Beyond the preview
Go deeper on NCT00970762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00970762.